Nabriva Therapeutics Announces Positive Topline Results from

Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA (lefamulin) in Adult Patients with Cystic Fibrosis

28.11.2022 - - PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE ... Seite 1

Related Keywords

Ireland , Dublin , Christine Guico Pabia , Cystic Fibrosis Foundation , Nasdaq , Chief Medical ,

© 2025 Vimarsana